-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, August 4 News On August 2, Fangsheng Pharmaceutical issued an announcement stating that it has decided to transfer the ownership of two drug varieties, "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium Granules" for 12 million yuan
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
On August 2, 2021, Fangsheng Pharmaceutical and its holding subsidiary, Red Panda Pharmaceuticals, signed the " Drug Marketing License Transfer Agreement", and decided to transfer the "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium" for RMB 12 million.
Ownership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
Ownership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
The announcement stated that this drug transfer is conducive to the integration of upstream and downstream resources of the subsidiary Red Panda Pharmaceuticals, relying on the "marketing license holder system" to vigorously promote the "production + sales" integrated operation model process, resulting in greater economic benefits
.
.
The children's compound Sivia Iron Powder is used to promote the development of infants and young children's bones, improve anemia and the adjuvant treatment of infants and young children's calcium deficiency.
The only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
The only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
Sales of compound Sivia railway terminal in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Children's four-dimensional calcium calcium granules are used to prevent and supplement children's vitamin and calcium deficiency.
There are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
There are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
Sales of terminal four-dimensional calcium calcium in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
The poor sales performance may be the reason why Fangsheng Pharmaceutical transferred the children's compound Sivia iron powder and children's four-dimensional calcium calcium granules
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
The price of this transaction was negotiated and determined by both parties, and the total transfer price of the variety was 12 million yuan
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
Data source: Mi Nei.
com database, company announcement
com database, company announcement
Medical Network, August 4 News On August 2, Fangsheng Pharmaceutical issued an announcement stating that it has decided to transfer the ownership of two drug varieties, "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium Granules" for 12 million yuan
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
On August 2, 2021, Fangsheng Pharmaceutical and its holding subsidiary, Red Panda Pharmaceuticals, signed the " Drug Marketing License Transfer Agreement", and decided to transfer the "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium" for RMB 12 million.
Ownership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
Ownership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
The announcement stated that this drug transfer is conducive to the integration of upstream and downstream resources of the subsidiary Red Panda Pharmaceuticals, relying on the "marketing license holder system" to vigorously promote the "production + sales" integrated operation model process, resulting in greater economic benefits
.
.
The children's compound Sivia Iron Powder is used to promote the development of infants and young children's bones, improve anemia and the adjuvant treatment of infants and young children's calcium deficiency.
The only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
The only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
Sales of compound Sivia railway terminal in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Children's four-dimensional calcium calcium granules are used to prevent and supplement children's vitamin and calcium deficiency.
There are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
There are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
Sales of terminal four-dimensional calcium calcium in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
The poor sales performance may be the reason why Fangsheng Pharmaceutical transferred the children's compound Sivia iron powder and children's four-dimensional calcium calcium granules
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
The price of this transaction was negotiated and determined by both parties, and the total transfer price of the variety was 12 million yuan
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
Data source: Mi Nei.
com database, company announcement
com database, company announcement
Medical Network, August 4 News On August 2, Fangsheng Pharmaceutical issued an announcement stating that it has decided to transfer the ownership of two drug varieties, "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium Granules" for 12 million yuan
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
.
According to data from Mi Nei.
com, in 2020, the sales of terminal compound Sivia iron in public medical institutions in China will be close to 9 million yuan, down 40.
61% year-on-year; the sales of Siwei calcium calcium exceed 10 million yuan, down 30.
26% year-on-year
.
On August 2, 2021, Fangsheng Pharmaceutical and its holding subsidiary, Red Panda Pharmaceuticals, signed the " Drug Marketing License Transfer Agreement", and decided to transfer the "Xiaoer Compound Sivia Iron Powder" and "Xiaoer Siwei Portuguese Calcium" for RMB 12 million.
Ownership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
Drugs Drugs Drugs Standard Standard StandardOwnership of the two drug varieties "granules"
.
The ownership of the above-mentioned drug varieties includes but is not limited to the production technology and intellectual property rights such as the original research materials, drug prescriptions, production technology and quality standards , re-registration materials and new drug certificates
.
The announcement stated that this drug transfer is conducive to the integration of upstream and downstream resources of the subsidiary Red Panda Pharmaceuticals, relying on the "marketing license holder system" to vigorously promote the "production + sales" integrated operation model process, resulting in greater economic benefits
.
.
The children's compound Sivia Iron Powder is used to promote the development of infants and young children's bones, improve anemia and the adjuvant treatment of infants and young children's calcium deficiency.
The only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
Children Children Children Hospital Hospital HospitalThe only domestic manufacturers are Hunan Nansheng Pharmaceutical and Changsha Dongfeng Pharmaceutical
.
According to data from Mi Nei.
com, in 2020, China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal compound Sivia railway sales are close to 9 million yuan, down 40.
61% year-on-year
.
Sales of compound Sivia railway terminal in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
Children's four-dimensional calcium calcium granules are used to prevent and supplement children's vitamin and calcium deficiency.
There are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
Child, child, kidThere are as many as 20 domestic manufacturers
.
According to data from Mi Nei.
com, in 2020, the sales of terminal four-dimensional calcium calcium in public medical institutions in China exceeded 10 million yuan, a year-on-year decline of 30.
26%
.
Sales of terminal four-dimensional calcium calcium in public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
The poor sales performance may be the reason why Fangsheng Pharmaceutical transferred the children's compound Sivia iron powder and children's four-dimensional calcium calcium granules
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
.
The announcement shows that the sales of Fangsheng Pharmaceutical's pediatric compound Sivia iron powder in 2019 and 2020 are 11.
54116 million yuan and 8.
2557 million yuan; the sales of pediatric Siwei calcium calcium granules in 2019 and 2020 are 1.
2438 million yuan and 1.
1413 million respectively.
Yuan
.
The price of this transaction was negotiated and determined by both parties, and the total transfer price of the variety was 12 million yuan
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
.
Among them, the price of children's compound Sivia iron powder is 11 million yuan, and the price of children's four-dimensional calcium calcium granules is 1 million yuan
.
Data source: Mi Nei.
com database, company announcement
com database, company announcement
